Kala Pharmaceuticals Inc (NASDAQ:KALA) - Share price


Stock Report

Kala Pharmaceuticals Inc KALA

Last Price
$0.30

Day Change
0.00|-0.73%

As of 01/07/2022
18:54:08 EDT | USD
Minimum 15 Minutes Delay.

Last Close0.30
Day Range0.28 - 0.31
Mkt Cap21.62Mil
52-Wk Range0.28 - 5.47
Yield %-
ISINUS4831191030
Volume1,486,952
P/E-
P/S2.17
P/CF-0.20

Share Price

Financials
201920202021
More ...
Income Statement
Revenue6.076.3611.24
Operating Income-88.22-96.23-109.43
Net Income-94.35-104.33-142.61
Basic EPS-2.76-1.99-2.19
Avg. Diluted Shares Outstanding345265
Balance Sheet
Current Assets105.48171.38124.37
Non Current Assets48.8450.2315.06
Total Assets154.32221.61139.43
Current Liabilities24.7722.2337.42
Total Liabilities---
Total Equity29.69100.0016.80
Cash Flow
Operating Cash Flow-92.72-90.69-108.24
Capital Expenditure-1.34-1.94-0.89
Free Cash Flow-94.06-92.64-109.12

In millions, except "Basic EPS". Currency is USD.

Company Profile

Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye. The company's two marketed products are EYSUVIS and INVELTYS.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Stock Style

Small-Value

Fiscal Year Ends

December

Employees

192
Key Stats
More ...
Price/Earning TTM-0.14
Price/Book-4.12
Price/Sales TTM1.74
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % TTM-973.60
Net Margin % TTM-1,268.73
ROE TTM-244.19
Debt/Equity4.73
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2022 Morningstar. All rights reserved.